| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TAYLOR GLEN A | 85% | +92% | $47,547,634 | +$37,432,500 | 68,909,614 | +370% | Glen A. Taylor | 12 Feb 2026 |
| Anzu SPAC GP I LLC | 11% | $3,806,377 | 2,718,841 | Anzu SPAC GP I LLC | 29 Sep 2023 | |||
| Ayrton Capital LLC | 7.9% | $1,695,994 | 2,457,963 | Ayrton Capital LLC | 31 Dec 2025 |
As of 31 Dec 2025, 25 institutional investors reported holding 1,299,264 shares of Envoy Medical, Inc. - Class A Common Stock (COCH). This represents 1.6% of the company’s total 81,261,337 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,299,264 | $858,979 | -$565,171 | $0.66 | 25 |
| 2025 Q3 | 2,123,532 | $1,649,025 | -$138,312 | $0.78 | 28 |
| 2025 Q2 | 2,306,452 | $3,275,197 | +$4,340 | $1.42 | 22 |
| 2025 Q1 | 2,303,397 | $2,998,325 | +$429,096 | $1.30 | 22 |
| 2024 Q4 | 2,015,076 | $2,945,656 | +$1,123,694 | $1.43 | 24 |
| 2024 Q3 | 1,032,950 | $3,330,106 | -$247,608 | $3.25 | 18 |
| 2024 Q2 | 1,162,015 | $2,742,612 | -$97,854 | $2.36 | 20 |
| 2024 Q1 | 1,173,098 | $4,593,072 | -$721,402 | $3.92 | 16 |
| 2023 Q4 | 1,646,603 | $3,013,128 | +$3,013,128 | $1.81 | 9 |